SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001140361-24-040318
Filing Date
2024-09-06
Accepted
2024-09-06 08:31:07
Documents
2
Group Members
YUEYING ZHU

Document Format Files

Seq Description Document Type Size
1 SC 13D ef20035609_sc13d.htm SC 13D 84240
2 EXHIBIT 1 ef20035609_ex99-1.htm EX-99.1 5080
  Complete submission text file 0001140361-24-040318.txt   90874
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82442 | Film No.: 241283026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12730 HIGH BLUFF DRIVE SUITE 250 SAN DIEGO CA 92130
Business Address
Ma Songjiang (Filed by) CIK: 0001985547 (see all company filings)

Type: SC 13D